Screener
Ginkgo Bioworks DNA Shares (Diluted)
Discontinued — last reported Q4 '25
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Ginkgo Bioworks’s 10-K, filed February 26, 2026.
- Filed
- Feb 26, 2026, 4:34 PM EST
- Fiscal year
- FY2025
- Accession
- 0001628280-26-012346
| Line item | Year Ended December 31, 2025 | Year Ended December 31, 2024 | Year Ended December 31, 2023 |
|---|---|---|---|
| Income tax benefit | (837) | (479) | (71) |
| Net loss | $(312,763) | $(547,029) | $(892,869) |
| Net loss per share | $(5.64) | $(10.54) | $(18.37) |
| Weighted average common shares outstanding: | 55,457,676 | 51,894,639 | 48,610,507 |
| Comprehensive loss: | |||
| Net loss | $(312,763) | $(547,029) | $(892,869) |
| Other comprehensive income (loss): | |||
| Foreign currency translation adjustment | 3,531 | (4,782) | 4,116 |
Item 16. Form 10-K Summary
FAQ
- What is Ginkgo Bioworks's shares (diluted)?
- Ginkgo Bioworks (DNA) reported shares (diluted) of 55.5M in Q4 2025.
- How has Ginkgo Bioworks's shares (diluted) changed year-over-year?
- Ginkgo Bioworks's shares (diluted) increased by 6.9% year-over-year, from 51.9M to 55.5M.
- What is the long-term trend for Ginkgo Bioworks's shares (diluted)?
- Over 4 years (2021 to 2025), Ginkgo Bioworks's shares (diluted) has grown at a -54.8% compound annual growth rate (CAGR), from 5.3B to 220.2M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Ginkgo Bioworks's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude